Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Acute accumulation of PIM2 and NRF2 and recovery of β5 subunit activity mitigate multiple myeloma cell susceptibility to proteasome inhibitors.
Int J Hematol. 2024 Mar;119(3):303-315. doi: 10.1007/s12185-023-03705-9. Epub 2024 Jan 21.
Int J Hematol. 2024.
PMID: 38245883
Elotuzumab-mediated ADCC with Th1-like Vγ9Vδ2 T cells to disrupt myeloma-osteoclast interaction.
Inoue Y, Tenshin H, Teramachi J, Sumitani R, Oda A, Maeda Y, Oura M, Sogabe K, Maruhashi T, Takahashi M, Fujii S, Nakamura S, Miki H, Hara T, Endo I, Kagawa K, Ozaki S, Hiasa M, Harada T, Abe M.
Inoue Y, et al.
Cancer Sci. 2024 Nov 18. doi: 10.1111/cas.16401. Online ahead of print.
Cancer Sci. 2024.
PMID: 39557586
Free article.
Item in Clipboard
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid.
Inoue Y, Oda A, Maeda Y, Sumitani R, Oura M, Sogabe K, Maruhashi T, Takahashi M, Fujii S, Nakamura S, Miki H, Hiasa M, Teramachi J, Harada T, Abe M.
Inoue Y, et al.
Int J Hematol. 2024 Jun;119(6):626-630. doi: 10.1007/s12185-024-03763-7. Epub 2024 Apr 6.
Int J Hematol. 2024.
PMID: 38581458
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.